Professional Documents
Culture Documents
Journal of Chromatography A
journal homepage: www.elsevier.com/locate/chroma
a r t i c l e i n f o a b s t r a c t
Article history: The properties of the complex between fragment B of Protein A and the Fc domain of IgG were investi-
Available online 18 April 2009 gated adopting molecular dynamics with the intent of providing useful insight that might be exploited to
design mimetic ligands with properties similar to those of Protein A. Simulations were performed both
Keywords: for the complex in solution and supported on an agarose surface, which was modeled as an entangled
mAbs structure constituted by two agarose double chains. The energetic analysis was performed by means of
Molecular dynamics
the molecular mechanics Poisson Boltzmann surface area (MM/PBSA), molecular mechanics generalized
IgG
Born surface area (MM/GBSA), and the linear interaction energy (LIE) approaches. An alanine scan was
Ligand
Chromatography
performed to determine the relative contribution of Protein A key amino acids to the complex interaction
Agarose energy. It was found that three amino acids play a dominant role: Gln 129, Phe 132 and Lys 154, though
also four other residues, Tyr 133, Leu 136, Glu 143 and Gln 151 contribute signicantly to the overall
binding energy. A successive molecular dynamics analysis of Protein A re-organization performed when
it is not in complex with IgG has however shown that Phe 132 and Tyr 133 interact among themselves
establishing a signicant interaction, which is disrupted upon formation of the complex with IgG
and thus reduces consistently their contribution to the proteinantibody bond. The effect that adsorbing
fragment B of Protein A on an agarose support has on the stability of the proteinantibody bond was
investigated using a minimal molecular model and compared to a similar study performed for a synthetic
ligand. It was found that the interaction with the surface does not hinder signicantly the capability
of Protein A to interact with IgG, while it is crucial for the synthetic ligand. These results indicate that
ligandsurface interactions should be considered in the design of new synthetic afnity ligands in order
to achieve results comparable to those of Protein A right from the ligand design stage.
2009 Elsevier B.V. All rights reserved.
1. Introduction that can satisfy the market requirements (enhancing the process
productivity to the gram per litre range), the huge potential of this
The pharmaceutical industry has recently demonstrated great class of molecules remains mostly limited by the difculties related
interest towards the use of biomacromolecules, such as proteins, to the scaling up of downstream processing technologies [5,6]. Due
peptides, and oligonucleotides as therapeutic agents [1,2]. In this to the complex structure of these immunoglobulins along with the
framework, a role of primary importance is played by monoclonal presence of a huge number of different compounds in the produc-
antibodies (mAbs). These molecules can be used both for diagnos- tion media, the purication is the crucial step of the whole process.
tic purposes (due to their high specicity towards a large number The most utilized purication methodologies are precipitation, ion-
of antigens) and for therapeutic use (to treat several diseases). As exchange chromatography, and afnity chromatography [7]. This
a result, a large-scale production (in the order of grams per litre) is last procedure is one of the most used as rst recovery step in the
required to be able to satisfy the mAbs world demand. At present, downstream processing of mAbs [8] and requires an appropriate
several mAbs (about 20) have been approved for sale by the US Food ligand, able to bind mAbs with high yield and selectivity.
and Drug Administration (FDA) and it is estimated that about 300 Before further discussing the afnity chromatography of mAbs,
are under development [3,4]. In the last 3 years the value of the it is necessary to have a molecular understanding of the nature of
mAb market has doubled, passing from US$ 10.3 109 in 2004 [3] the interaction between mAbs and afnity ligands. Since human
to 20.6 109 in 2006, and it keeps growing at such a rate that it has antibodies are classied into ve different families (named A, D,
been recently depicted as a new gold rush [5]. While the produc- E, G and M), for sake of simplicity in this discussion we will refer
tion technologies of mAbs have been developed reaching results to the G class (IgG), which is the most common. IgG and, more in
general, monoclonal antibodies are large globular proteins charac-
terized by a complex structure in which two variable domains (Fab)
Corresponding author. are linked through disulde bonds with a constant region: the Fc
E-mail address: carlo.cavallotti@polimi.it (C. Cavallotti). domain. The Fc domain is divided in two equal parts, which rela-
0021-9673/$ see front matter 2009 Elsevier B.V. All rights reserved.
doi:10.1016/j.chroma.2009.04.035
M. Salvalaglio et al. / J. Chromatogr. A 1216 (2009) 86788686 8679
Fig. 2. Agarose molecular model used in the simulations of the supported systems.
2.2. Simulation approach
support, and the third a model of IgG in complex with a synthetic All the simulations were performed in explicit water in a cubic
ligand, namely A2P, supported on an agarose substrate. box using a non-bonded cutoff of 10 . Periodic boundary condi-
The A2P system is the same described in our previous publica- tions (PBC) were applied and long range electrostatic interactions
tion [19] and is composed of four parts: the ligand, a spacer, the were evaluated using the particle mesh Ewald (PME) method [39].
agarose support, and the full Fc domain of IgG. Support, spacer and MD simulations were performed following a ve-step protocol
ligand are covalently bonded and bind the protein through elec- consisting of:
trostatic and van der Waals forces. The energetic and structural
parameters of the A2P complex here reported are the same dis-
(i) 2000 cycles minimization to remove any possible unfavor-
cussed in our previous paper [19], to which we refer for the details
able contact between solvent and solute; in this step the
of the simulations. Here we report however some unpublished data
complex is restrained with a harmonic potential of the form
that are of interest for the direct comparison with the Protein AIgG
k(x)2 , where x is the displacement and k the force constant
system.
(k = 500 kcal mol1 2 );
The molecular model adopted to investigate the interaction
(ii) 1500 cycles minimization without restraints;
between IgG and Protein A is the X-ray structure determined by
(iii) simulated annealing of 20 ps at constant volume to raise the
Deisenhofer, deposited in the pdb with code 1FC2 [35]. The Deisen-
temperature of the system from 0 to 300 K; in this phase, a weak
hofer structure consists of fragment B of Protein A, just about one
restraint is imposed on the complex (k = 10 kcal mol1 2 ) to
fth of the whole protein, and by half Fc domain of the antibody.
avoid wild structural uctuations;
Clearly, this is only a small portion of the whole Protein AIgG
(iv) 100 ps run at constant pressure (equilibration phase) to allow
complex. However, despite its relatively limited size, this complex
the water density to relax;
is generally considered as a good model of the complex between
(v) MD run for a standard period of 1018 ns at constant pressure
Protein A (or G) and IgG [9,35], as it comprehends all the IgG bind-
and temperature (300 K).
ing site and most of its surroundings. In order to reproduce the
steric constraint acting on half Fc domain when covalently bound
to its symmetric partner in the whole Fc macrostructure, we have In all the simulation steps the temperature has been controlled
imposed a distance restraint on the two terminal residues of the with a Langevin dynamics algorithm, with a collision frequency
antibody. In this way we could avoid the relative bending of the = 1 ps1 . The pressure in the equilibration phase is controlled by
CH2 and CH3 domains. Moreover, since the separation of the mAbs means of a weak coupling Berendsen scheme. The SHAKE algorithm
by means of afnity chromatography is carried out in a pH range was used to restrain all the covalent bonds involving hydrogen,
next to pH 7, we have considered the His residues not protonated which allowed using a time step of 2.0 fs [40]. Structures to be used
for all the simulations. for successive analysis were extracted every 500 fs.
The model of the Protein AIgGsupport complex is composed Binding free energies between protein and ligands were deter-
by three parts: the agarose support, fragment B of Protein A and the mined using the linear interaction energy (LIE), the molecular
(half) Fc domain of IgG. The structure of the Protein AIgG molecular mechanics Poisson Boltzmann surface area (MM/PBSA), and the
model is the same used to study the complex in solution. To study molecular mechanics generalized Born surface area (MM/GBSA)
the effect of the support, fragment B of Protein A has been covalently approaches. The fundamental hypothesis on which these methods
bound to the agarose support by means of an ester bond between rest and their consequent accuracy is discussed in the following, as
a glucose monomer unit and the backbone of the peptidic ligand. it is relevant to the interpretation of the results.
The molecular model used to represent the agarose support is As reported in the literature [41], the LIE approach is based
composed of two double helixes involved in an entangled structure, on the main assumption that the free energy of interaction of a
as described in detail in [18]. This structure was obtained by means molecule with the surrounding environment is linearly correlated
of a 30 ns equilibration MD run starting from two parallel double both to electrostatic (ELE) and van der Waals (VdW) interactions.
helixes. The initial coordinates for a single double helix structure This assumption is useful in order to evaluate the free energy differ-
were taken from the Protein Data Bank (PDB ID 1AGA [37]) and the ence between two different states, free and bound, of the solute. In
MD run was performed using an explicit solvation shell of TIP3P [38] the free state the surrounding environment is constituted only by
water molecules. After 15 ns the system converged to the structure water molecules, while in the bound state the environment com-
reported in Fig. 2, which was maintained for the successive 15 ns. prehends also the receptor.
The adopted molecular model of Protein A supported on an According to LIE theory, the free binding energy can then be
agarose surface should be regarded as an extremely simplied computed as
model of the real agaroseProtein A system because of the limited vdw V vdw ) + (V ele V ele )
G = (Vbound (1)
size of agarose and since we considered only a fragment of Protein A. free bound free
M. Salvalaglio et al. / J. Chromatogr. A 1216 (2009) 86788686 8681
Table 1 lower G limit using respectively the maximum and the minimum
Optimal and values for the evaluation of G contributions as a function of charge
values for the and coefcients reported in Table 1.
and of total number of hydroxyl groups [41].
Binding free energies of the Fc domain of IgG1 with the frag-
Charge No. of OH groups ment B of Protein A were also determined using the MM/PBSA
=
/ 0 0.5 0.181 and MM/GBSA approaches. These theoretical approaches, origi-
0 0 0.43 0.181 nally proposed by Kollman and co-workers [45], are based on the
0 1 0.37 0.181 assumption that binding free energies of a ligand L with a protein P
0 2 0.33 0.181
can be determined as the sum of different contributions as:
Vse = Vse (L L) + Vse (L E) + Vse (E E) (2) which correspond to changes in internal energy (composed by bond
stretching, angular deformation and torsional energy), electrostatic
where e stands for ELE or VdW, s for bound or free, L for ligand and energy (expressed as Coulomb interaction between point charges),
E for environment. and van der Waals energy (expressed through Lennard Jones poten-
The ELE and the VdW terms of the force eld were computed by tials). GSol is the difference between the solvation free energy
means of sums over all the non-bonded pairs, which were divided of the complex (GSol LP) and that of the ligand (GSol L) and
into subgroups. IgG(GSol P). Solvation free energies were implicitly determined
A fundamental assumption of the adopted LIE model is that the using either the PoissonBoltzmann approach or generalized Born
internal re-organization of the environment can be considered neg- theory. Finally, TSgas is the entropy difference between complex,
ligible: in other words we are assuming a lock and key behavior of ligand and protein and was here calculated only considering the
the system in which the non-bonded potential of interaction of the rotational and translation contributions, which were determined
atoms making part of the environment is constant. This assumption through statistical thermodynamics making reference to the cor-
can be expressed as responding molecular partition functions. The vibrational entropy
e e contribution has thus been neglected, mainly because of the dif-
Vbound (E E) Vfree (E E) (3)
culty of estimating it accurately for these large proteins. This is
The introduction of Eq. (3) in Eq. (2) leads to the simplication likely to cause an uncertainty of a few kcal/mol in the free bind-
of the (E E) terms and thus to the following expression: ing energies estimated using these computational approaches. The
TSgas contribution for the Protein AIgG complex is 28 kcal/mol.
V e = Vbound
e e
Vfree e
= (Vbound e
(L L) + Vbound (L E) The energetic terms appearing in Eq. (6) were averaged over the
e e e e
structures that the ligandprotein complex can assume during the
+Vbound (E E))(Vfree (L L)+Vfree (L E) + Vfree (E E)) MD simulations.
MD simulations were performed using the Amber 8 computa-
= V e (L L) + V e (L E) (4) tional suite [46], all structures reported in this work were produced
where the superscript e refers to electrostatic or van der Waals using either PyMol 1.3 [47] or VMD 1.8.2 [48]. The parm94 [49]
interactions, L to ligand and E to environment. The Ve (L E) term force eld was adopted to model proteins and ligands while the
is directly related to the interactions that take place between lig- glycam 04 [50] and TIP3P [38] force elds were used for agarose
and and environment during the binding process, while Ve (L L) and water, respectively. The interaction energies between solute
is determined by the reorganization of the ligand upon passing and environment were determined with the Anal program of the
from the bound to the free state. This auto-interaction term can Amber 8 computational suite.
be neglected for small ligands such as A2P but can become impor-
tant for peptidic ligands such as Protein A or other complex ligands 3. Results and discussion
[42]. The lock and key assumption was found reasonable for systems
solvated in water [43,44], while it does not hold inside a protein, 3.1. Modeling the Protein AIgG interaction
for example for the binding site of an enzyme. The consensus bind-
ing site of IgG is characterized by the capability to establish both The interaction between fragment B of Protein A and the human
electrostatic and hydrophobic interactions, which might involve a IgG1 Fc fragment was investigated with the aim of calculating the
certain re-organization of the amino acids involved in the forma- free binding energy of the complex and to determine which are the
tion of the bond with the ligand. It is thus difcult to estimate a residues of Protein A that contribute most to the binding energy. A
priori whether Eq. (3) holds for this system and this aspect must be better understanding of the nature of the bond between Protein A
considered as a source of uncertainty for the calculations reported and IgG can in fact help to guide the design of improved synthetic
in the next section. ligands for mAbs. As mentioned, the starting structure for the MD
The and coefcients of Eq. (1) are dependent on the chemical simulations was the crystal structure determined by Deisenhofer
properties of the solute, and in particular on the number of OH [35] and deposited in the Protein Data Bank as 1FC2. The 1FC2 struc-
groups. A recent survey has proposed the values reported in Table 1 ture is composed by one of the twin CH3CH2 domains of IgG1 and
[41]. by fragment B of Protein A, which is the Fc binding domain of Protein
The and values reported in Table 1 have been determined A, and is reported in Fig. 3.
for small molecules with a semi-empirical approach, and thus can- The bond between fragment B of Protein A and IgG involves the
not be straightforwardly applied to Protein A, which is a large and hinge region located between the CH2 and CH3 domains of IgG and
complex solute. Thus, in order to evaluate the order of magnitude several amino acids of Protein A. As previously reported [9], the
of G with a simple approach we have calculated an upper and a region between the CH2 and CH3 domains of IgG is known to be
8682 M. Salvalaglio et al. / J. Chromatogr. A 1216 (2009) 86788686
Fig. 4. Free binding energy of the IgGProtein A complex calculated using the
MM/PBSA MM/GBSA and the LIE approach ( = 0.181, = 0.5) and reported as a
function of simulation time.
Table 2
Free binding energies calculated using the
MM/PBSA, MM/GBSA and LIE approaches and
averaged over the whole simulation time span.
G [kcal/mol]
Fig. 3. Structure of the Protein AFc complex used as staring point for the simula- MM/PBSA 7.4
tions. MM/GBSA 5.6
LIE 9.2
Exp [12] 9.8
able to bind several proteins beyond Protein A, such as the domain
C2 of Protein G, the rheumatoid factor, and the neonatal Fc recep-
ods and also with the available experimental data. The calculated
tor. The physicalchemical properties of the CBS that make it able to
free binding energies averaged over the whole simulation time span
coordinate several proteins are: a capability to form strong hydro-
are reported in Table 2.
gen (H) bonds, a high degree of solvent accessibility, an exposed
Since the LIE approach is sensible to the and values adopted
hydrophobic surface, a high adaptability and mobility of the con-
in Eq. (1), we analyzed in detail the effect of their variation between
sensus region, and the capability to change the relative orientation
the maximum ( = 0.181, = 0.5) and minimum ( = 0.181, = 0.37)
of the CH2 and CH3 domains. What is most interesting is that the
values reported in Table 1, which provides thus a sort of uncertainty
Fc binding region can coordinate different residues of proteins that
bar. The value reported in Table 2 is the average between those two
greatly differ in their secondary structure. This suggests that, on the
limits.
basis of a deep understanding of the chemical and physical prop-
Electrostatic (Vele ) and van der Waals (VVdW ) contributions
erties of this region, it might be possible to devise a set of rules
to the interaction energy are reported separately in Fig. 5. Both the
to be used in the synthesis of molecules with improved binding
components of the total energy of interaction are of the same order
properties [9,14,15,51,52].
of magnitude, which means that the binding process is driven by
The conformational evolution of the Protein AIgG complex was
studied through a 18 ns MD simulation in explicit water. A similar
simulation was performed for Protein A in solution to determine its
conformational evolution when IgG is not present.
The free binding energy between protein and antibody was then
calculated as a function of simulation time using the MM/PBSA,
MM/GBSA, and LIE approaches with standard = 0.181 and = 0.5
parameters. The results are summarized in Fig. 4.
It can be noted that the free binding energies predicted adopt-
ing the three different methods differ signicantly in the rst 2 ns
of simulation, after which they converge to a constant value. Taking
as a reference the free energy proles determined employing the
MM/PBSA and MM/GBSA methods, it can be observed that the LIE
free energy shows signicant uctuations at the 10th and 16th ns.
While the initial incoherence between the MM-based methods and
the LIE approach can be ascribed to the equilibration of the solvent
molecules (that are explicitly considered by the LIE approach and
substituted with continuum models in the other cases), these uc-
tuations are most likely due to an instantaneous violation of the
lock and key hypotheses expressed with Eq. (3). Despite of this, the
LIE free binding energy averaged over the whole simulation time Fig. 5. Protein A VdW and electrostatic energy change contributions in the solvated
span is coherent with the averages obtained with the other meth- complex.
M. Salvalaglio et al. / J. Chromatogr. A 1216 (2009) 86788686 8683
Fig. 7. Variation of free binding energies calculated replacing key amino acids of
Protein A with alanine residues using the MM/GBSA protocol.
Fig. 11. Time evolution of the distances between the two agarose units that interact most with IgG and the centre of mass of the CH3 domain of IgG for the IgGProtein A and
IgGA2P complexes.
8686 M. Salvalaglio et al. / J. Chromatogr. A 1216 (2009) 86788686
tial energy surface; the limited size of the agarose surface model; [8] S. Hober, K. Nord, M. Linhult, J. Chromatogr. B 848 (2007) 40.
the description of the solvent as a pure water environment, thus [9] W.L. DeLano, M.H. Ultsch, A.M. de Vos, J.A. Wells, Science 287 (2000) 1279.
[10] A.C.A. Roque, C.S.O. Silva, M.A. Taipa, J. Chromatogr. A 1160 (2007) 44.
neglecting the effect of salt and other biomolecules that are usually [11] K. Huse, H.J. Bohme, G.H. Scholz, J. Biochem. Biophys. Methods 51 (2002)
present in real feedstocks and that are known to affect the separa- 217.
tion process. While such assumptions make the molecular model [12] R.X. Li, V. Dowd, D.J. Stewart, S.J. Burton, C.R. Lowe, Nat. Biotechnol. 16 (1998)
190.
here presented more close to an ideal system than to a faithful [13] H. Yang, P.V. Gurgel, R.G. Carbonell, J. Peptide Res. 66 (2006) 120.
description of a real chromatographic process, some conclusions [14] G. Fassina, M. Ruvo, G. Palombo, A. Verdoliva, M. Marino, J. Biochem. Biophys.
can be drawn that can help to interpret what already is known Methods 49 (2001) 481.
[15] G. Fassina, A. Verdoliva, M.R. Odierna, M. Ruvo, G. Cassini, J. Mol. Recognit. 9
or suspected for this type of interactions, as well as to shed new (1996) 564.
light on the properties of this important protein-protein complex. [16] A.R. Newcombe, C. Cresswell, S. Davies, K. Watson, G. Harris, K. ODonovan, R.
In particular we found that: Francis, J. Chromatogr. B 814 (2005) 209.
[17] K. Sproule, P. Morrill, J.C. Pearson, S.J. Burton, K.R. Hejnaes, H. Valore, S. Lud-
vigsen, C.R. Lowe, J. Chromatogr. B 740 (2000) 17.
(i) The interaction energy between Protein A and IgG is deter- [18] V. Busini, D. Moiani, D. Moscatelli, L. Zamolo, C. Cavallotti, J. Phys. Chem. B 110
mined both by electrostatic and van der Waals interactions. (2006) 23564.
(ii) The alanine scan analysis evidenced that the key residues [19] L. Zamolo, V. Busini, D. Moiani, D. Moscatelli, C. Cavallotti, Biotechnol. Prog. 24
(2008) 527.
involved in the proteinantibody bond are: Gln 129, Phe 132 [20] P. DePhillips, I. Lagerlund, J. Farenmark, A.M. Lenhoff, Anal. Chem. 76 (2004)
and Lys 154, followed by Tyr 133, Leu 136, Glu 143 and Gln 151. 5816.
(iii) The LIE energetic analysis suggests that the role played by Phe [21] S.Y. Suen, S.Y. Lin, H.C. Chiu, Ind. Eng. Chem. Res. 39 (2000) 478.
[22] X.K. Xu, A.M. Lenhoff, J. Phys. Chem. B 112 (2008) 1028.
132 and Tyr 133 might be overemphasized by alanine scanning [23] E. Riccardi, J.C. Wang, A.I. Liapis, J. Phys. Chem. B 112 (2008) 7478.
calculations, since their interaction energy with the antibody [24] S. Nita, N.M. Cann, J. Phys. Chem. B 112 (2008) 13022.
is counterbalanced by the strong intra-molecular interaction [25] K. Makrodimitris, E.J. Fernandez, T.B. Woolf, J.P. OConnell, Anal. Chem. 77 (2005)
1243.
they develop among themselves in solution. The A2P syn- [26] K. Makrodimitris, D.L. Masica, E.T. Kim, J.J. Gray, J. Am. Chem. Soc. 129 (2007)
thetic ligand, which design was inspired from these two amino 13713.
acids, maintains intact its capability to interact because the [27] J.G. Chen, R.X. Wang, M. Taussig, K.N. Houk, J. Org. Chem. 66 (2001) 3021.
[28] Y.M. Pan, D.Q. Gao, C.G. Zhan, J. Am. Chem. Soc. 130 (2008) 5140.
self-interaction of the two functional groups of which it is com- [29] R. Barderas, J. Desmet, P. Timmerman, R. Meloen, J.I. Casal, Proc. Natl. Acad. Sci.
posed, which mimic Phe 132 and Tyr 133, is sterically hindered. U.S.A. 105 (2008) 9029.
(iv) Differently from what found for the complex between IgG [30] C. Arcangeli, C. Cantale, P. Galef, G. Gianese, R. Paparcone, V. Rosato, J. Biomol.
Struct. Dyn. 26 (2008) 35.
and the A2P synthetic ligand, the adsorption of fragment B
[31] J. Morll, J. Neumann, K. Blank, U. Steinbach, E.M. Puchner, K.E. Gottschalk, H.E.
of Protein A on an agarose support material does not limit its Gaub, J. Mol. Biol. 381 (2008) 1253.
capability to interact with the antibody. [32] J. Sengupta, P. Sinha, C. Mukhopadhyay, P.K. Ray, Biochem. Biophys. Res. Com-
mun. 256 (1999) 6.
[33] L. Jendeberg, M. Tashiro, R. Tejero, B.A. Lyons, M. Uhlen, G.T. Montelione, B.
We believe that the results here reported can be exploited to Nilsson, Biochemistry 35 (1996) 22.
develop an efcient strategy for the development of Protein A [34] K. Kato, L.Y. Lian, I.L. Barsukov, J.P. Derrick, H.H. Kim, R. Tanaka, A. Yoshino, M.
mimetic ligands, which, in our opinion, would be most success- Shiraishi, I. Shimada, Y. Arata, G.C.K. Roberts, Structure 3 (1995) 79.
[35] J. Deisenhofer, Biochemistry 20 (1981) 2361.
ful if it combined systematic ligand development methods, such as [36] E.O. Saphire, P. Parren, R. Pantophlet, M.B. Zwick, G.M. Morris, P.M. Rudd, R.A.
screening of combinatorial libraries, with computational tools sim- Dwek, R.L. Staneld, D.R. Burton, I.A. Wilson, Science 293 (2001) 1155.
ilar to those presented in this work. Our results however suggest [37] S. Arnott, A. Fulmer, W.E. Scott, I.C.M. Dea, R. Moorhouse, D.A. Rees, J. Mol. Biol.
90 (1974) 269.
that it is imperative, in the search for a new ligand, that support [38] W.L. Jorgensen, J. Chandraskhar, J.D. Madura, R.W. Impey, M.L. Klein, J. Phys.
and ligand are optimized together right from the initial in silico or Chem. 79 (1983) 926.
in vitro screening of the combinatorial library. [39] D.A. Case, T.E. Cheatham, T. Darden, H. Gohlke, R. Luo, K.M. Merz, A. Onufriev,
C. Simmerling, B. Wang, R.J. Woods, J. Comput. Chem. 26 (2005) 1668.
[40] J.P. Ryckaert, G. Ciccotti, H.J.C. Berendsen, J. Comput. Phys. 23 (1977) 320.
Acknowledgements [41] T. Hansson, J. Marelius, J. Aqvist, J. Comput. Aided Mol. Des. 12 (1998) 27.
[42] D. Moiani, C. Cavallotti, A. Famulari, C. Schmuck, Chem. Eur. J. 14 (2008) 5207.
[43] M. Almlof, J. Aqvist, A.O. Smalas, B.O. Brandsdal, Biophys. J. 90 (2006) 433.
This work has been performed as part of the Advanced Inter-
[44] M. Almlof, B.O. Brandsdal, J. Aqvist, J. Comput. Chem. 25 (2004) 1242.
active Materials by Design (AIMs) project, supported by the Sixth [45] J. Wang, P. Morin, W. Wang, P.A. Kollman, J. Am. Chem. Soc. 123 (2001) 5221.
Research Framework Program of the European Union (NMP3-CT- [46] D.A. Case, T.A. Darden, T.E. Cheatham III, C.L. Simmerling, J. Wang, R.E. Duke,
R. Luo, K.M. Merz, B. Wang, D.A. Pearlman, M. Crowley, S. Brozell, V. Tsui, H.
2004-500160).
Gohlke, J. Mongan, V. Hornak, G. Cui, P. Beroza, C. Schafmeister, J.W. Caldwell,
W.S. Ross, P.A. Kollman, AMBER 8, University of California, San Francisco, CA,
References 2004.
[47] W.L. DeLano, The PyMOL Molecular Graphics System, DeLano Scientic, San
Carlos, CA, 2002.
[1] K. Keller, T. Friedmann, A. Boxman, Trends Biotechnol. 19 (2001) 438.
[48] W. Humphrey, A. Dalke, K. Schulten, J. Mol. Graphics 14 (1996) 33.
[2] A.C.A. Roque, C.R. Lowe, M.A. Taipa, Biotechnol. Prog. 20 (2004) 639.
[49] W.D. Cornell, P. Cieplak, C.I. Bayly, I.R. Gould, K.M. Merz Jr., D.M. Ferguson, D.C.
[3] S.J. Kim, Y. Park, H.J. Hong, Mol. Cells 20 (2005) 17.
Spellmeyer, T. Fox, J.W. Caldwell, P.A. Kollman, J. Am. Chem. Soc. 117 (1995)
[4] D. Filpula, Biomol. Eng. 24 (2007) 201.
5179.
[5] K. Maggon, Curr. Med. Chem. 14 (2007) 1978.
[50] K.N. Kirschner, R.J. Woods, Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 10541.
[6] A.A. Shukla, B. Hubbard, T. Tressel, S. Guhan, D. Low, J. Chromatogr. B 848 (2007)
[51] Y.D. Clonis, J. Chromatogr. A 1101 (2006) 1.
28.
[52] C.R. Lowe, Curr. Opin. Chem. Biol. 5 (2001) 248.
[7] D. Low, R. OLeary, N.S. Pujar, J. Chromatogr. B 848 (2007) 48.